GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,005,000 | +19.6% | 9,243 | -36.4% | 0.01% | +25.0% |
| Q4 2020 | $1,677,000 | -0.8% | 14,542 | -13.2% | 0.00% | -20.0% |
| Q3 2020 | $1,690,000 | -22.5% | 16,753 | -5.6% | 0.01% | -28.6% |
| Q2 2020 | $2,180,000 | -12.2% | 17,743 | -37.6% | 0.01% | -30.0% |
| Q1 2020 | $2,484,000 | – | 28,440 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |